Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...] …
Year: 2023
Critics of the 340B program, including a former congressman who voted to create the program, have written recent editorials urging [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The 340B drug pricing program allows covered entities serving vulnerable patient populations to buy medications at a discount. Since 1987, AIDS Healthcare Foundation has been on the frontline of the HIV response in the United States. AHF cares for patients regardless
…
When I thought about launching 340B Report, the first person I reached out to was Tom Mirga. Tom and I [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators recently deferred a decision on whether to add identifiers to 340B drugs purchased under Medicare Part D. The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
After 30 years of serving vulnerable populations, the 340B Drug Pricing Program has grown considerably in scale and complexity. While it is arguably one of the most successful public/private partnerships in healthcare history, 340B is facing policy obstacles and headwinds that can make
…
Who will succeed retiring Rep. Anna Eshoo (D-Calif.) as top Democrat on the House Energy & Commerce (E&C) subcommittee that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
